共 50 条
- [24] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS) [J]. BMC Pharmacology and Toxicology, 24
- [25] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS) [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
- [27] Opioids and frequency counts in the US Food and Drug Administration Adverse Event Reporting System (FAERS) database: a quantitative view of the epidemic [J]. DRUG HEALTHCARE AND PATIENT SAFETY, 2019, 11 : 65 - 70